Cell And Developmental Biology
-
Ken Lau and Eunyoung Choi named 2024 Stanley Cohen Innovation Fund awardees
Eunyoung Choi and Ken Lau receive funding for novel cancer research, which may ultimately result in cancer detection and treatment options for patients. The fund supports early-stage, high-risk high-reward research projects and honor Cohen’s seminal discoveries, which led to the invention of many anticancer drugs used today. Read MoreNov. 21, 2024
-
Vanderbilt building molecular atlas of colorectal cancer across different stages of disease onset with $5 million National Cancer Institute grant
Colorectal cancer is the second leading cause of cancer-related deaths in the U.S. Ken Lau and Jeffrey Spraggins are creating the first spatially mapped atlas characterizing the progression trajectories of early-onset colorectal cancer versus average-onset CRC as they transition from precancerous lesions to malignant cancers. Read MoreNov. 20, 2024
-
Anthony Venida deliver Discovery Science Emerging Scholar Lecture on Nov. 19
HHMI Hanna Gray postdoctoral fellow Anthony Venida will present the Discovery Science Emerging Scholar Lecture on Tuesday, Nov. 19. Read MoreNov. 14, 2024
-
Celebrating recent appointments and promotions in the School of Medicine Basic Sciences
Congratulations to our School of Medicine Basic Sciences members who were promoted or received new appointments from July to September 2024. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read MoreNov. 14, 2024
-
Nobel laureate Venki Ramakrishnan talks aging, mortality, and scientific innovation in Apex Lecture
Nobel Prize winner Venki Ramakrishnan delivered a captivating talk as part of the School of Medicine Basic Sciences Apex Lecture Series. His presentation was based on his best-selling book, Why We Die, which explores the biological mechanisms behind aging and death and humanity's efforts to prolong life. Read MoreNov. 14, 2024
-
Determining the precise timing of cellular growth to understand the origins of cancer
Mirazul Islam, a graduate student in the lab of Professor Ken Lau, has developed a molecular clock that records the timing of cellular events at a single-cell resolution. Read MoreOct. 31, 2024
-
Robert J. Kleberg Jr. and Helen C. Kleberg Foundation Grant funds quest to expand immunotherapy efficacy for colorectal cancer
Coffey and Lau plan to uncover the mechanistic underpinnings of supermeres in the tumor microenvironment, look for other immune exclusion biomarkers, and evaluate the efficacy of immunotherapy when immune exclusion proteins are targeted. Read MoreOct. 7, 2024
-
Shedding light on a decades-old protein sorting mystery
Christian de Caestecker, a Ph.D. student in the lab of Ian Macara, Louise B. McGavock Professor and chair of the Department of Cell and Developmental Biology, proposed and validated a mechanism that solved a decades-old mystery: he shed light on the process by which epithelial cells, polarized cells that face the outside world, sort and deliver the specialized proteins they need at each cell’s poles. Read MoreSep. 24, 2024
-
Alan Hurtado, Ph.D. candidate in the Chemical and Physical Biology Program, was named inaugural Linda Sealy Emerging Scholar Travel Award recipient
Ph.D. candidate Alan Hurtado and his mentor, Edward Levine, William A. Black Professor of Ophthalmology and professor of cell and developmental biology, will attend the leading conference in their field, the annual meeting of the Association for Research in Vision and Ophthalmology, thanks to support from the Linda Sealy Emerging Scholar Travel Award. Read MoreSep. 16, 2024
-
Promising drug-like compounds found to have strong action against blood cancers
For researchers, projects can sometimes feel like babies, and there is nothing more satisfying than seeing your baby grow up. For William Tansey, professor of cell and developmental biology, this baby started 10 years ago when he and Stephen Fesik, Orrin H. Ingram II, Professor of Cancer Research and professor of biochemistry, discovered that a protein called WDR5 is a “partner in crime” to MYC, a transcription factor and oncogene that is often mutated in cancers. In fact, dysregulation of MYC is estimated to be responsible for about a third of all cancer deaths annually. Read MoreSep. 3, 2024